(Q46689232)

24 December 2017

title

Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable (English)

1 reference

24 December 2017

0 references

0 references

1 reference

1

1 reference

24 December 2017

author name string

R Andrezina

2

1 reference

24 December 2017

V Milanova

3

1 reference

24 December 2017

P Glue

4

1 reference

24 December 2017

M Masiak

5

1 reference

24 December 2017

M St John Turner

6

1 reference

24 December 2017

R Medori

7

1 reference

24 December 2017

W Gaebel

8

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

24 December 2017

Journal of Psychopharmacology

published in

1 reference

24 December 2017

volume

19

1 reference

24 December 2017

issue

5 Suppl

1 reference

24 December 2017

page(s)

5-14

1 reference

24 December 2017

Pharmacological management of first-episode schizophrenia and related nonaffective psychoses

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Is earlier better? At the beginning of schizophrenia: timing and opportunities for early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Treatment of schizophrenia: preventing the progression of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Schizophrenia practice guidelines: international survey and comparison.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Recovery from psychotic illness: a 15- and 25-year international follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Pharmacotherapy of first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Time course and biologic correlates of treatment response in first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

A selective review of recent North American long-term followup studies of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

The profiles of clinical deterioration in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Early detection and intervention with schizophrenia: rationale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Self-awareness of cognitive functioning in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Symptom response and side-effects of olanzapine and risperidone in young adults with recent onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Rationale for the study of early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

Guidelines for depot antipsychotic treatment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105056513

21 January 2018

Identifiers

DOI

10.1177/0269881105056513

1 reference

24 December 2017

1 reference

24 December 2017